LusineMTumyanMD

PubMed

• Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategies.
  Eliza R Bacon, Kena Ihle, Weihua Guo, Colt A Egelston, Diana L Simons, Christina Wei, Lusine Tumyan, Daniel Schmolze, Peter P Lee, James R Waisman> ;NPJ Precision Oncology. 2024 Mar 29
• 15 citations
  NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.
  Therese B Bevers, Bethany L Niell, Jennifer L Baker, Debbie L Bennett, Ermelinda Bonaccio, Melissa S Camp, Sona Chikarmane, Emily F Conant, Mohammad Eghtedari, Meghan ...> ;Journal of the National Comprehensive Cancer Network. 2023 Sep 1
• 1 citations
  Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer.
  Yuan Yuan, Susan E Yost, Yujie Cui, Christopher Ruel, Mireya Murga, Aileen Tang, Norma Martinez, Daniel Schmolze, James Waisman, Niki Patel, Lalit Vora, Lusine Tumyan,...> ;The Oncologist. 2023 Jul 5
• 2 citations
  Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer.
  Sayeh M Lavasani, George Somlo, Susan E Yost, Paul H Frankel, Christopher Ruel, Yujie Cui, Mireya Murga, Aileen Tang, Norma Martinez, Laura Kruper, Lusine Tumyan, Dani...> ;Cancer. 2023 Mar 1
• 9 citations
  Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine (T-DM1) for Metastatic Breast Cancer: A Pilot Study.
  Joanne E. Mortimer, James R. Bading, Paul Frankel, Mary Caroll, Yuan Yuan, Jinha M. Park, Lusine Tumyan, Nikita Gidwaney, Erasmus Poku, John E. Shively, David Colcher> ;Journal of Nuclear Medicine. 2021 Dec 1
• 18 citations
  Towards integration of 64Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer.
  Angela M. Jarrett, David A. Hormuth, Vikram Adhikarla, Prativa Sahoo, Daniel Abler, Lusine Tumyan, Daniel Schmolze, Joanne E. Mortimer, Russell C. Rockne, Thomas E. Ya...> ;Scientific Reports. 2020 Nov 25
• 345 citations
  Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.
  Therese B. Bevers, Mark A. Helvie, Ermelinda Bonaccio, Kristine E. Calhoun, Mary B. Daly, William B. Farrar, Judy Garber, Richard Gray, Caprice C. Greenberg, Rachel A....> ;Journal of the National Comprehensive Cancer Network. 2018 Nov 1
• 6 citations
  Socioeconomic and Clinical Factors Are Key To Uncovering Disparity in Accrual Onto Therapeutic Trials for Breast Cancer
  Carolyn E. Behrendt, Arti Hurria, Lusine Tumyan, Joyce C. Niland, Joanne E. Mortimer> ;Journal of the National Comprehensive Cancer Network. 2014 Nov 1
• 7 citations
  Evaluation of expert criteria for preoperative magnetic resonance imaging of newly diagnosed breast cancer
  Carolyn E. Behrendt, Lusine Tumyan, Laura Gonser, Sara L. Shaw, Lalit Vora, I. Benjamin Paz, Joshua D. I. Ellenhorn, John H. Yim> ;Breast. 2014 Aug 1
• 29 citations
  Negative predictive value of sonography and mammography in patients with focal breast pain.
  Lusine Tumyan, Anne C. Hoyt, Lawrence W. Bassett> ;The Breast Journal. 2005 Sep 1
• Join now to see all